Johnson & Johnson agreed to pay $5.5 billion to resolve remaining lawsuits alleging its talc products caused ovarian cancer. The agreement requires 95% of remaining claimants to participate and is intended to end more than a decade of litigation.
Johnson & Johnson agreed to pay $5.5 billion to resolve remaining lawsuits alleging its talc products caused ovarian cancer. The agreement requires 95% of remaining claimants to participate and is intended to end more than a decade of litigation.